This review (24 studies; n=416) found that ketamine is a reliable fast-acting anti-depressant for patients suffering from treatment-resistant depression (TRD). Long-term effects, however, remain to be studied.
- Published
- Journal
- Current Neuropharmacology
- Authors
- Serafini, G., Howland, R. H., Rovedi, F., Girardi, P., Amore, M.